What are the criteria and steps to assess extubation readiness in pediatric patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How to Assess Extubation Readiness in Pediatrics

Use a protocolized extubation readiness testing (ERT) bundle that includes daily screening, a spontaneous breathing trial (SBT), sedation assessment, evaluation of secretion management, and consideration of upper airway obstruction risk—this structured approach reduces extubation failure rates and improves outcomes. 1

Core Framework: The ERT Bundle Approach

The 2023 PALISI international guidelines establish that extubation readiness assessment should follow a systematic, protocolized approach rather than relying solely on clinical judgment 1. This bundle-based strategy has been shown to reduce extubation failure rates from 12.9% to 2.4% when properly implemented 2.

Step 1: Daily Safety Screening (Eligibility Assessment)

Before proceeding with formal testing, verify the child meets these safety criteria 1:

  • Gas exchange: Adequate oxygenation on acceptable FiO₂ (typically ≤0.5)
  • Hemodynamic stability: No active shock, stable vasoactive support
  • Neurologic status: Appropriate level of consciousness for age
  • No planned procedures requiring sedation in next 12-24 hours
  • Ventilator settings: Reasonable support levels (consider mean airway pressure >10 cm H₂O as a negative predictor) 3

Step 2: Sedation and Airway Assessment

Evaluate three critical elements before proceeding 1:

  1. Sedation level: Use a validated sedation scale (e.g., COMFORT-B, State Behavioral Scale) to ensure appropriate arousal—not too deep, not agitated 1
  2. Cough effectiveness: Must demonstrate adequate cough strength to clear secretions
  3. Secretion management: Assess volume and character of endotracheal and oropharyngeal secretions—60% of providers delay extubation for significant secretions 4

Critical pitfall: Approximately 60% of pediatric cardiac ICUs do not consistently use validated sedation scales 4, yet sedation assessment is a core component of safe extubation.

Step 3: Spontaneous Breathing Trial (SBT)

Perform an SBT as the objective centerpiece of extubation readiness assessment 1:

SBT Method Selection:

  • Standard-risk patients: Use either pressure support (PS) with CPAP OR CPAP alone 1
  • High-risk patients (see Table 4 criteria below): Use CPAP alone WITHOUT pressure support—PS augmentation underestimates post-extubation work of breathing and may lead to premature extubation 1

SBT Duration:

  • Standard-risk patients: 30 minutes is acceptable 1
  • High-risk patients: 60-120 minutes provides better assessment 1

High-risk populations include 1:

  • Younger age (especially <1 year)
  • Prolonged mechanical ventilation
  • Cardiac disease
  • Neuromuscular conditions
  • Chronic lung disease
  • Obesity

Step 4: Respiratory Muscle Strength Assessment

Measure maximal inspiratory pressure (PiMax) in children at risk for muscle weakness or extubation failure 1. Risk factors include:

  • Prolonged mechanical ventilation
  • Neuromuscular disease
  • Prolonged corticosteroid or neuromuscular blocker use
  • Sepsis
  • Malnutrition
  • Chronic illness

While specific pediatric thresholds are not well-established, recent data suggests diaphragmatic excursion >5.5 mm on ultrasound (sensitivity 100%, specificity 91.7%) and diaphragmatic thickening fraction >29% are the strongest predictors of extubation success 5.

Emerging evidence: The rapid shallow breathing index (RSBI) ≥4.62 breaths/min/mL/kg identifies children at increased risk of extubation failure after cardiac surgery (sensitivity 84.6%, specificity 94.0%) 6.

Step 5: Upper Airway Obstruction (UAO) Risk Assessment

For children with cuffed endotracheal tubes, perform an air leak test 1:

High-risk UAO populations 1:

  • Multiple intubation attempts
  • Traumatic intubation
  • Large-for-age endotracheal tube
  • ETT air leak pressure >25 cm H₂O for cuffed tubes
  • Anatomical airway anomalies

Corticosteroid Prophylaxis:

Administer dexamethasone at least 6 hours before extubation in high-risk children 1. Key points:

  • Early administration (>6-12 hours pre-extubation) is more effective than late administration
  • Both high-dose (>0.5 mg/kg) and low-dose regimens work when given early
  • If given <6 hours before extubation, use higher doses (>0.5 mg/kg)
  • Do not delay extubation to complete a dexamethasone course in standard-risk patients 1

The evidence shows dexamethasone reduces UAO incidence (205 fewer cases per 1,000 patients) but has unclear benefit on overall extubation failure rates 1.

Step 6: Post-Extubation Respiratory Support Planning

For high-risk patients, plan noninvasive respiratory support (NRS) immediately after extubation 1:

  • Children <1 year: Use CPAP over high-flow nasal cannula (HFNC) 1
  • Older children: HFNC, CPAP, or NIV are all acceptable
  • If respiratory distress develops on conventional oxygen: Escalate to NRS rather than continuing conventional therapy 1

This approach is supported by 91.9% of providers using HFNC as their primary noninvasive support method 4.

Practical Implementation Algorithm

12-24 hours before anticipated extubation:

  1. For cuffed ETT: Measure air leak pressure
  2. If leak pressure >25 cm H₂O or high UAO risk: Give dexamethasone

On day of extubation:

  1. Perform safety screening (gas exchange, hemodynamics, neurologic status, ventilator settings)
  2. Assess sedation with validated tool
  3. Evaluate cough and secretions
  4. If all pass → Proceed to SBT
  5. Measure PiMax if muscle weakness risk
  6. Conduct SBT (method and duration based on risk stratification)
  7. If SBT passes → Extubate to appropriate respiratory support

If safety screening fails:

  • From cardiopulmonary perspective: Repeat in 12-24 hours
  • From sedation perspective: Optimize sedation, repeat in 12-24 hours

Critical Nuances and Pitfalls

Variability in practice remains substantial despite guidelines—only 43.7% of pediatric cardiac ICU providers routinely perform SBTs, and 39.8% do not use validated sedation scales 4. This variability likely contributes to inconsistent outcomes.

The evidence quality is limited: Most recommendations carry "very low certainty of evidence" with conditional strength 1. However, the bundle approach represents best available evidence and expert consensus.

Extubation failure definitions vary: Most define it as reintubation within 24-48 hours 7, 4, though some studies use longer timeframes. The 48-hour window is most commonly used in practice.

Special populations require modified approaches: Children with congenital heart disease, particularly those with single-ventricle physiology or cyanotic lesions, may require more intensive assessment, though cyanotic lesions alone do not predict ERT failure 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.